Vyome Holdings, Inc. (HIND) vs SeaStar Medical Holding Corporation (ICU)

Vyome Holdings, Inc. and SeaStar Medical Holding Corporation are both Biotechnology companies. Vyome Holdings, Inc. and SeaStar Medical Holding Corporation are of similar size ($13.5M and $13.4M). SeaStar Medical Holding Corporation has negative trailing earnings, so its P/E is not meaningful; Vyome Holdings, Inc. trades at 0.0×. SeaStar Medical Holding Corporation grew revenue faster over the last twelve months: 123.6% against 103.8%. SeaStar Medical Holding Corporation has the higher net margin (−795.5% vs −8,711.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Vyome Holdings, Inc. leads on 8 and SeaStar Medical Holding Corporation on 7.

Valuation

Metric HIND ICU Biotechnology median
P/E 0.00 n/m 8.50
P/S 101.12 6.99 9.71
P/B 1.80 2.79 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 138.64 4.42 9.21
Earnings yield 81,732.03% (133.45%) (33.15%)
Free cash flow yield (42.50%) (114.43%) (25.50%)

Profitability

Metric HIND ICU Biotechnology median
Gross margin 52.77% 92.64% 65.16%
Operating margin (9,184.82%) (816.75%) 0.00%
Net margin (8,711.71%) (795.50%) 0.00%
Free cash flow margin (4,298.00%) (799.36%) 0.00%
Return on equity (172.10%) (356.87%) (56.36%)
Return on assets (124.23%) (160.02%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric HIND ICU Biotechnology median
Revenue growth (TTM) 103.81% 123.63% 6.02%
EPS growth (last fiscal year) 99.92% 91.16% 30.26%
Revenue growth, 5-year CAGR (50.98%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HIND ICU Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.37 1.89 4.72
Net debt to EBITDA 0.48 0.99 0.96

Dividend

Metric HIND ICU Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric HIND ICU Biotechnology median
Market cap 13.41m 13.48m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack